A question of rigour.
Bowler
Phil
P
D000464:Alginates / Q000009:adverse effects / Q000627:therapeutic use*; D000818:Animals; D002266:Carboxymethylcellulose Sodium / Q000009:adverse effects / Q000627:therapeutic use*; D004195:Disease Models, Animal; D005122:Exudates and Transudates; D020723:Glucuronic Acid / Q000009:adverse effects / Q000627:therapeutic use; D006603:Hexuronic Acids / Q000009:adverse effects / Q000627:therapeutic use; D008422:Materials Testing; D009779:Occlusive Dressings / Q000009:adverse effects / Q000592:standards*; D018030:Silver Compounds / Q000009:adverse effects / Q000627:therapeutic use*; D013552:Swine; D013997:Time Factors; D016896:Treatment Outcome; D014945:Wound Healing; D014947:Wounds and Injuries / Q000473:pathology / Q000628:therapy*
D000464:Alginates; D006603:Hexuronic Acids; D018030:Silver Compounds; D020723:Glucuronic Acid; D002266:Carboxymethylcellulose Sodium